What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Enzyme
His main research concerns Alzheimer's disease, Internal medicine, Biomarker, Pathology and Alzheimer's Disease Neuroimaging Initiative.
His Alzheimer's disease research incorporates elements of Neuroimaging, Cerebrospinal fluid, Neuroscience and Dementia, Cognitive decline.
His biological study spans a wide range of topics, including Endocrinology, Neurology, Oncology and Cardiology.
His study looks at the intersection of Biomarker and topics like Disease with Clinical trial, Intensive care medicine, Psychiatry, Bioinformatics and Clinical study design.
Leslie M. Shaw has researched Pathology in several fields, including Positron emission tomography and Magnetic resonance imaging.
In his research, Senile plaques and Neurodegeneration is intimately related to Alzheimer's disease biomarkers, which falls under the overarching field of Alzheimer's Disease Neuroimaging Initiative.
His most cited work include:
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade (2965 citations)
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. (2323 citations)
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. (1523 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Pathology, Disease, Cerebrospinal fluid and Alzheimer's disease.
His Internal medicine study integrates concerns from other disciplines, such as Endocrinology, Neuroimaging and Oncology.
Leslie M. Shaw is involved in the study of Pathology that focuses on Atrophy in particular.
His Disease study combines topics in areas such as Clinical trial, Neuroscience and Intensive care medicine.
Leslie M. Shaw combines subjects such as Positron emission tomography, Neurodegeneration and Amyloid with his study of Cerebrospinal fluid.
Leslie M. Shaw has included themes like Apolipoprotein E and Degenerative disease in his Alzheimer's disease study.
He most often published in these fields:
- Internal medicine (34.53%)
- Pathology (19.20%)
- Disease (19.33%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (34.53%)
- Disease (19.33%)
- Cerebrospinal fluid (17.87%)
In recent papers he was focusing on the following fields of study:
Leslie M. Shaw focuses on Internal medicine, Disease, Cerebrospinal fluid, Oncology and Biomarker.
His Internal medicine study combines topics from a wide range of disciplines, such as Cognition, Endocrinology and Neuroimaging.
In general Disease, his work in Csf biomarkers and Alzheimer's disease is often linked to Pre analytical linking many areas of study.
His Cerebrospinal fluid research entails a greater understanding of Pathology.
The study incorporates disciplines such as Positron emission tomography and Apolipoprotein E in addition to Oncology.
His work carried out in the field of Biomarker brings together such families of science as Neurology, Clinical trial and Parkinson's disease.
Between 2017 and 2021, his most popular works were:
- CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts (181 citations)
- Current state of Alzheimer's fluid biomarkers. (175 citations)
- Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative (100 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Enzyme
His primary areas of investigation include Internal medicine, Cerebrospinal fluid, Disease, Biomarker and Pathology.
His Internal medicine research incorporates themes from Gastroenterology, Endocrinology, Neuroimaging and Oncology.
The concepts of his Cerebrospinal fluid study are interwoven with issues in Frontotemporal dementia, Tau phosphorylation, Reproducibility, Positron emission tomography and Amyloid.
His Alzheimer's disease study, which is part of a larger body of work in Disease, is frequently linked to Clinical Practice, bridging the gap between disciplines.
His Biomarker research includes elements of Clinical trial, Neurodegeneration, Immunology, Dementia and Neurology.
His research in Pathology focuses on subjects like Magnetic resonance imaging, which are connected to Primary progressive aphasia and Posterior cortical atrophy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
